Free Trial

Dr. Reddy's Laboratories (RDY) News Today

Dr. Reddy's Laboratories logo
$75.20
-3.24 (-4.13%)
(As of 10/29/2024 ET)
Dr. Reddy’s Launches Groundbreaking Drug in India
Journey Medical announces presentation of DFD-29 data
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories Stock Set to Split on Tuesday, November 5th (NYSE:RDY)
Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) shares are scheduled to split before the market opens on Tuesday, November 5th. The 5-1 split was announced on Thursday, September 12th. The newly created shares will be payable to shareholders after the market closes on Monday, November 4th.
Dr. Reddy's Laboratories Limited stock logo
Zacks Research Has Optimistic Outlook of RDY Q2 Earnings
Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research increased their Q2 2027 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a research note issued to investors on Wednesday, October 16th. Zacks Research analyst R. Department now expects that the company w
Dr. Reddy's Laboratories Limited stock logo
Zacks Research Comments on Dr. Reddy's Laboratories Limited's Q2 2026 Earnings (NYSE:RDY)
Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Equities researchers at Zacks Research boosted their Q2 2026 EPS estimates for shares of Dr. Reddy's Laboratories in a research report issued on Wednesday, October 16th. Zacks Research analyst R. Department now anticipates that the compa
Dr. Reddy's Laboratories Limited stock logo
Artemis Investment Management LLP Has $4.71 Million Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Artemis Investment Management LLP grew its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 280.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 59,306 shares of the co
Dr. Reddy’s Unveils New Danish Subsidiary
Dr. Reddy's Laboratories Limited stock logo
Sei Investments Co. Sells 26,041 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)
Sei Investments Co. lowered its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 66.8% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,935 shares of the company's stock after selling 26,041 shares during the q
Dr. Reddy's Laboratories Limited stock logo
Healthcare of Ontario Pension Plan Trust Fund Acquires 283,700 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)
Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 318.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 372,900 sh
Dr. Reddy's Laboratories Limited stock logo
Creative Planning Purchases 16,157 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)
Creative Planning increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 22.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 87,522 shares of the company's stock after buying an
Dr. Reddy’s Acquires Global NRT Leader Nicotinell
Dr. Reddy's Laboratories Limited stock logo
Dimensional Fund Advisors LP Increases Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Dimensional Fund Advisors LP lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 12.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,003,782 shares of the company's stock afte
Dr. Reddy's Laboratories Limited stock logo
XTX Topco Ltd Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)
XTX Topco Ltd acquired a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,305 shares of the company's stock,
Dr. Reddy's Laboratories Limited stock logo
American Century Companies Inc. Has $11.19 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)
American Century Companies Inc. grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 8.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 146,823 shares of the company's stock a
Dr. Reddy's Laboratories Limited stock logo
34,557 Shares in Dr. Reddy's Laboratories Limited (NYSE:RDY) Acquired by Frank Rimerman Advisors LLC
Frank Rimerman Advisors LLC purchased a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 34,557 shares of the company's st
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories Limited (NYSE:RDY) is Promethos Capital LLC's 7th Largest Position
Promethos Capital LLC boosted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 14.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,734 shar
Dr. Reddy's Laboratories Limited stock logo
Mondrian Investment Partners LTD Sells 22,329 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)
Mondrian Investment Partners LTD decreased its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 13.6% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 142,218 shares of the company's stock after selling 22,329 sha
Dr. Reddy's Laboratories Limited stock logo
Renaissance Technologies LLC Purchases 65,606 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)
Renaissance Technologies LLC increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 3.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,995,495 shares of the company's stock aft
Dr. Reddy's Laboratories Limited stock logo
Rhumbline Advisers Trims Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Rhumbline Advisers reduced its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 19.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 75,643 shares of the company's stock after selling 18,782 shares during the period. Rhumbline Advisers'
Dr. Reddy's Laboratories Limited stock logo
Natixis Advisors LLC Purchases New Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Natixis Advisors LLC acquired a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 10,202 shares of the company's stock, valued at
Dr. Reddy's Laboratories Limited stock logo
Zacks Research Brokers Lower Earnings Estimates for Dr. Reddy's Laboratories Limited (NYSE:RDY)
Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research lowered their FY2027 EPS estimates for shares of Dr. Reddy's Laboratories in a research note issued on Wednesday, September 11th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $3
Dr. Reddy's Laboratories Limited (RDY)
Dr. Reddy's Laboratories Limited stock logo
Caprock Group LLC Invests $997,000 in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Caprock Group LLC bought a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 13,080 shares of the company's stock, valued at app
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories Limited (NYSE:RDY) Stock Position Increased by Acadian Asset Management LLC
Acadian Asset Management LLC increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 37.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 269,131 shares of the company's sto
Dr. Reddy's Laboratories Limited stock logo
National Bank of Canada FI Has $13.88 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)
National Bank of Canada FI grew its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 81.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 184,120 shares of the company's stock after purchas
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories Limited (NYSE:RDY) Sees Significant Growth in Short Interest
Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Free Report) was the recipient of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 2,270,000 shares, an increase of 20.1% from the July 31st total of 1,890,000 shares. Based on an average daily trading volume, of 250,200 shares, the short-interest ratio is currently 9.1 days.
Dr. Reddy's Laboratories Limited stock logo
Allspring Global Investments Holdings LLC Cuts Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Allspring Global Investments Holdings LLC decreased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 17.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,260
Dr. Reddy's Laboratories Limited stock logo
Panagora Asset Management Inc. Has $11.57 Million Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Panagora Asset Management Inc. raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 20.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 151,841 shares of the company's stock after buying an addi
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. decreased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 62.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 60,048 shares of the company's stock aft
Dr. Reddy's Laboratories Limited stock logo
FY2025 EPS Estimates for Dr. Reddy's Laboratories Limited (NYSE:RDY) Decreased by Zacks Research
Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Equities researchers at Zacks Research decreased their FY2025 earnings estimates for shares of Dr. Reddy's Laboratories in a research report issued to clients and investors on Wednesday, August 14th. Zacks Research analyst R. Department
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down to $83.32
Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down to $83.32
Dr. Reddy's Laboratories Limited stock logo
Artemis Investment Management LLP Raises Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Artemis Investment Management LLP grew its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 92.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,600 shares of the compan
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories (NYSE:RDY) Hits New 12-Month High at $84.03
Dr. Reddy's Laboratories (NYSE:RDY) Hits New 1-Year High at $84.03
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Vanguard Group Inc.
Vanguard Group Inc. trimmed its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 1.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,019,011 shares of the compa
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Purchased by Jane Street Group LLC
Jane Street Group LLC raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 2,197.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 113,168 shares of the company's stock after purchasing a
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories (NYSE:RDY) Price Target Raised to $87.00
Barclays raised their price objective on shares of Dr. Reddy's Laboratories from $81.00 to $87.00 and gave the company an "overweight" rating in a research note on Tuesday.
Dr. Reddy's Laboratories Limited stock logo
Bellevue Group AG Sells 20,004 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)
Bellevue Group AG reduced its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 32.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 40,896 shares of the company's stock after sellin
Dr. Reddy's Laboratories Limited stock logo
Dr. Reddy's Laboratories (NYSE:RDY) Hits New 12-Month High at $82.89
Dr. Reddy's Laboratories (NYSE:RDY) Reaches New 52-Week High at $82.89
Dr. Reddy's Q1FY25 Financial Results
Get Dr. Reddy's Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter.

This is treason (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

RDY Media Mentions By Week

RDY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RDY
News Sentiment

0.22

0.67

Average
Medical
News Sentiment

RDY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RDY Articles
This Week

7

3

RDY Articles
Average Week

Get Dr. Reddy's Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:RDY) was last updated on 10/30/2024 by MarketBeat.com Staff
From Our Partners